{"id":"F2006L02523","name":"National Health Act 1953 - Determination under subsection 85B(1) (No. PB 34 of 2006)","slug":"national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":59756,"registerId":"commonwealth-F2006L02523-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Determination under subsection 85B(1) (No. PB 34 of 2006)","content":"PBS Determination 85BCOMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDETERMINATION UNDER SUBSECTION 85B(1)\n\nNo. PB 34 of 2006\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subsection 85B(1) of the National Health Act 1953 (referred to in this Determination as “the Act”), hereby make the following Determination:\n\n1. This Determination commences on 1 August 2006.\n2. Determination No. PB 27 of 2006 under subsection 85B(1) of the National Health Act 1953, made on 15 June 2006 with effect from 1 July 2006, is repealed.\n3. In this Determination “authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is a prescription authorised in accordance with paragraph 12 of the determinations made under sections 85, 85A and 88 of the Act.\n4. Section 85B of the Act applies in relation to each of the brands of the pharmaceutical benefits specified in Part A of the Schedule to this Determination (referred to in this Determination as “the Schedule”).\n5. For the purposes of paragraph 85B(1)(c) of the Act, the quantity or number of units that is relevant for the purpose of determining an amount referred to in paragraph 85B (1) (d) or 85B(1)(e) of the Act in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the quantity or number of units specified in Part B of the Schedule in relation to the brand of the pharmaceutical benefit.\n6. For the purposes of paragraph 85B(1)(d) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part C of the Schedule in relation to the brand of the pharmaceutical benefit.\n7. For the purposes of paragraph 85B(1)(e) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the price claimed by the manufacturer as the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part D of the Schedule in relation to the brand of the pharmaceutical benefit.\n\n8. Notwithstanding anything else in this Determination, section 85B of the Act will not apply in respect of the pharmaceutical benefits listed in the following table if the prescription which directs the supply of the pharmaceutical benefit was written before 1 April 2006 and supply is made before 1 October 2006:\n\n| Drug or medicinal preparations | Form (strength, type, size, etc) | Brand |\n| ------------------------------ | ---------------------------------------------------------------- | ----- |\n| Lansoprazole | Sachet containing granules for oral suspension, 30 mg per sachet | WY |\n\n9. The name of the manufacturer or the names of manufacturers denoted in accordance with the following table by letters appearing in the column headed “Brand” in Part A of the Schedule in relation to a pharmaceutical benefit specified in that Part of the Schedule is or are the brand or brands of the pharmaceutical benefit referred to in paragraphs 4, 5, 6 and 7:\n\n| Letters | Manufacturer's Name | Letters | Manufacturer's Name |\n| ------- | ------------------- | ------- | ------------------- |\n\n| AB | Abbott Australasia Pty Ltd |\n| --- | ----------------------------------------------------------------------------------------- |\n| AG | Allergan Australia Pty Ltd |\n| AL | Alphapharm Medical A Division of Alphapharm Pty Limited |\n| AP | AstraZeneca Pty Ltd |\n| AQ | Alcon Laboratories (Australia) Pty Ltd |\n| AS | Aspen Pharmacare Australia Pty Ltd |\n| AV | Aventis Pharma Pty Limited |\n| BN | Bayer Australia Limited |\n| BP | British Pharmaceuticals |\n| BQ | Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd |\n| BX | Baxter Healthcare Pty Limited |\n| BY | Boehringer Ingelheim Pty Limited |\n| CS | CSL Limited |\n| DT | DermaTech Laboratories Pty Ltd |\n| FR | Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd |\n| GC | GlaxoSmithKline Consumer Healthcare |\n| GK | GlaxoSmithKline Australia Pty Ltd |\n| HX | Hexal Australia Pty Ltd |\n| JC | Janssen-Cilag Pty Ltd |\n| KN | Knoll A Division of Abbott Australasia Pty Ltd |\n| LU | Lundbeck Australia Pty Ltd |\n| LY | Eli Lilly Australia Pty Limited |\n| MK | Merck Sharp & Dohme (Australia) Pty Ltd |\n| ML | Marion Division of Aventis Pharma Pty Limited |\n| MM | 3M Pharmaceuticals Australia Pty Ltd |\n| MQ | Merck Pharmaceuticals |\n| MX | Mayne Pharma Pty Ltd |\n| NM | Novartis Medicines A Division of Novartis Pharmaceuticals Australia Pty Ltd |\n| NV | Novartis Pharmaceuticals Australia Pty Ltd |\n| OR | Organon (Australia) Pty Limited |\n| PC | Pfizer Consumer Healthcare Pty Ltd |\n| PF | Pfizer Pty Limited |\n| PH | Pharmacia Australia Pty Limited |\n| RO | Roche Products Pty Ltd |\n| SC | Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin |\n| SE | Servier Laboratories (Aust.) Pty Ltd |\n| SG | Serono Australia Pty Ltd |\n| SI | Sigma Pharmaceuticals Pty Ltd |\n| SM | Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd |\n| SU | Sauter Laboratories (Aust.) Pty Ltd |\n| SW | Sanofi-Synthelabo Australia Pty Limited |\n| SZ | Sandoz Pty Ltd |\n| UC | UCB Pharma A Division of UCB Australia Pty Ltd |\n| VT | Valeant Pharmaceuticals Australasia Pty Ltd |\n| WY | Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited |\n\n```html\n

Aciclovir

Tablet 200 mg

GK

25

38.25

40.88

GK

90

139.97

143.86

Tablet 800 mg

GK

35

169.57

171.47

GK

120

562.55

569.46

Alendronate Sodium

Tablet equivalent to 70 mg alendronic acid

MK

4

42.85

43.60

Allopurinol

Tablet 100 mg

SI

200

7.85

9.99

Tablet 300 mg

SI

60

4.64

6.64

Alprazolam

Tablet 250 micrograms

PH

50

3.62

4.57

Tablet 500 micrograms

PH

50

5.86

6.88

Tablet 1 mg

PH

50

10.21

11.41

Tablet 2 mg

PH

50

15.81

17.26

Aluminium Hydroxide - Dried with Magnesium Hydroxide

Tablet 200 mg-200 mg

PC

100

3.49

3.67

Oral suspension 200 mg-200 mg per 5 mL, 500 mL

PC

1

3.49

3.63

Amiodarone Hydrochloride

Tablet 100 mg

SW

30

10.00

10.88

Tablet 200 mg

SW

30

17.76

18.64

Amlodipine Besylate

Tablet equivalent to 5 mg amlodipine (unless supplied on an authority prescription)

PF

30

13.86

17.92

Tablet equivalent to 10 mg amlodipine (unless supplied on an authority prescription)

PF

30

24.39

30.28

Amoxycillin Trihydrate

Tablet equivalent to 1 g amoxycillin

SZ

14

5.06

6.42

GK

14

5.06

6.42

Capsule equivalent to 250 mg amoxycillin

GK

20

2.47

3.38

Capsule equivalent to 500 mg amoxycillin

GK

20

4.91

5.82

Amoxycillin Trihydrate with Potassium Clavulanate

Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid

GK

10

6.65

7.55

Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid

GK

10

9.48

10.66

Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP

Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL

GK

1

4.09

4.96

Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL

GK

1

5.84

6.73

Amoxycillin Trihydrate with Water - Purified BP

Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL

GK

1

2.20

3.31

Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL

GK

1

3.17

4.09

Aspirin

Tablet 100 mg

MX

112

1.41

2.61

Atenolol

Tablet 50 mg

AP

30

4.46

7.59

Azathioprine

Tablet 25 mg

GK

100

35.66

37.04

Tablet 50 mg

GK

100

60.71

62.02

Baclofen

Tablet 10 mg

NV

100

29.74

32.37

Tablet 25 mg

NV

100

65.05

67.69

Betamethasone Valerate

Cream equivalent to 200 micrograms betamethasone per g, 100 g

SI

1

3.76

4.90

Cream equivalent to 500 micrograms betamethasone per g, 15 g

SI

1

1.89

3.54

Ointment equivalent to 500 micrograms betamethasone per g, 15 g

SI

1

1.89

3.54

Betaxolol Hydrochloride

Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL

AQ

1

7.19

8.96

Bleomycin Sulfate

Powder for injection 15,000 I.U.

MX

1

47.66

90.54

BQ

10

476.63

979.29

SI

10

476.63

905.38

Brimonidine Tartrate

Eye drops 2 mg per mL, 5 mL

AG

1

12.93

14.47

Brinzolamide

Eye drops 10 mg per mL, 5 mL

AQ

1

12.93

13.82

Bromocriptine Mesylate

Tablet equivalent to 2.5 mg bromocriptine

NV

30

12.67

15.25

NV

60

25.32

27.97

Capsule equivalent to 5 mg bromocriptine

NV

60

49.79

52.44

Capsule equivalent to 10 mg bromocriptine

NV

100

178.33

181.24

Bupropion Hydrochloride

Tablet 150 mg (sustained release)

GK

30

65.71

66.50

GK

90

150.38

151.17

Captopril

Tablet 12.5 mg

BQ

90

11.89

14.13

Tablet 25 mg

BQ

90

17.21

19.45

Tablet 50 mg

BQ

90

33.95

36.19

Carbamazepine

Tablet 100 mg

NV

200

14.75

17.12

Tablet 200 mg

NV

200

27.57

30.30

Carbomer 980

Ocular lubricating gel 2 mg per g, 10 g

NV

1

3.63

4.52

Cefaclor Monohydrate

Tablet (sustained release) equivalent to 375 mg cefaclor

AS

10

7.51

10.15

Cefaclor Monohydrate with Water - Purified BP

Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL

AS

1

5.28

7.59

Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL

AS

1

5.65

8.04

Cefotaxime Sodium

Powder for injection equivalent to 1 g cefotaxime

SZ

1

2.14

4.54

Powder for injection equivalent to 2 g cefotaxime

SZ

1

3.97

8.39

Cephalexin

Capsule 250 mg (anhydrous)

AS

20

2.81

4.98

Capsule 500 mg (anhydrous)

AS

20

5.04

7.62

Cephalexin with Water - Purified BP

Granules for oral suspension 125 mg per 5 mL, 100 mL

AS

1

3.35

5.60

Granules for oral suspension 250 mg per 5 mL, 100 mL

AS

1

4.97

7.54

Cephalothin Sodium

Powder for injection equivalent to 1 g cephalothin

AS

10

34.15

34.41

Cephazolin Sodium

Powder for injection equivalent to 1 g cephazolin

AS

10

55.76

57.96

Cimetidine

Tablet 200 mg

GK

120

17.35

19.62

Tablet 400 mg

GK

60

17.35

19.62

Ciprofloxacin Hydrochloride

Tablet equivalent to 250 mg ciprofloxacin

BN

14

23.08

24.76

Tablet equivalent to 500 mg ciprofloxacin

BN

14

45.10

46.78

Tablet equivalent to 750 mg ciprofloxacin

BN

14

67.97

69.64

Eye drops equivalent to 3 mg ciprofloxacin per mL, 5 mL

AQ

1

10.89

11.99

Citalopram Hydrobromide

Tablet equivalent to 20 mg citalopram

LU

28

20.40

23.21

Clarithromycin

Tablet 250 mg

AB

14

8.62

10.39

Clindamycin Hydrochloride

Capsule equivalent to 150 mg clindamycin

PH

25

12.33

13.61

Clomiphene Citrate

Tablet 50 mg

AV

10

30.93

34.21

SG

10

30.93

31.09

Clomipramine Hydrochloride

Tablet 25 mg

NV

50

12.07

15.04

Clonazepam

Tablet 500 micrograms

RO

100

7.99

10.07

Tablet 2 mg

RO

100

15.02

17.38

Codeine Phosphate with Paracetamol

Tablet 30 mg-500 mg

SW

20

1.92

3.59

Colchicine

Tablet 500 micrograms

AS

100

3.82

4.62

Cyclosporin

Capsule 25 mg

HX

30

34.97

36.01

NV

30

34.97

37.07

Capsule 50 mg

HX

30

73.58

74.62

NV

30

73.58

75.67

Capsule 100 mg

HX

30

150.85

151.90

NV

30

150.85

153.17

Cyproterone Acetate

Tablet 50 mg

SC

20

55.76

59.93

SC

50

122.20

129.98

Tablet 100 mg

SC

50

197.98

208.88

Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin

Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL

AV

1

2.08

3.64

Diazepam

Tablet 2 mg

RO

50

1.80

2.95

SU

50

1.80

2.59

Tablet 5 mg

RO

50

2.00

3.16

SU

50

2.00

2.83

Diclofenac Sodium

Tablet 25 mg (enteric coated)

NV

50

3.85

5.30

Tablet 50 mg (enteric coated)

NV

50

5.37

8.18

Digoxin

Tablet 62.5 micrograms

SI

200

3.31

4.89

Tablet 250 micrograms

SI

100

3.56

5.15

Diltiazem Hydrochloride

Tablet 60 mg

AV

90

12.98

15.30

Capsule 180 mg (controlled delivery)

AV

30

14.40

16.72

Capsule 240 mg (controlled delivery)

AV

30

19.44

21.76

Capsule 360 mg (controlled delivery)

AV

30

25.49

28.31

Diphenoxylate Hydrochloride with Atropine Sulfate

Tablet 2.5 mg-25 micrograms

PH

20

1.71

3.33

Dothiepin Hydrochloride

Capsule 25 mg

AB

50

2.31

3.25

Tablet 75 mg

AB

30

2.57

3.51

Doxepin Hydrochloride

Capsule equivalent to 10 mg doxepin

PF

50

1.98

3.60

Capsule equivalent to 25 mg doxepin

PF

50

2.31

3.68

Doxycycline Hydrochloride

Tablet equivalent to 50 mg doxycycline

PF

25

4.23

5.68

Capsule equivalent to 50 mg doxycycline (containing enteric coated pellets)

MX

25

4.23

5.74

Tablet equivalent to 100 mg doxycycline

PF

7

2.37

3.76

Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets)

MX

7

2.37

3.70

MX

21

7.07

9.49

Enalapril Maleate

Tablet 5 mg

FR

30

7.78

10.64

MK

30

7.78

10.64

Tablet 10 mg

FR

30

12.78

15.64

MK

30

12.78

15.64

Tablet 20 mg

FR

30

16.28

19.14

MK

30

16.28

19.14

Erythromycin

Capsule 250 mg (containing enteric coated pellets)

MX

25

3.49

5.05

Erythromycin Ethyl Succinate

Tablet equivalent to 400 mg erythromycin

AB

25

3.20

5.75

Erythromycin Ethyl Succinate with Water - Purified BP

Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL

AB

1

2.88

4.81

Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL

AB

1

4.31

5.86

Escitalopram Oxalate

Tablet equivalent to 10 mg escitalopram (unless supplied on an authority prescription)

LU

28

20.40

23.31

Tablet equivalent to 20 mg escitalopram (unless supplied on an authority prescription)

LU

28

34.00

38.86

Oral solution equivalent to 10 mg escitalopram per mL, 28 mL (unless supplied on an authority prescription)

LU

1

27.54

31.47

Famotidine

Tablet 20 mg

MK

60

12.75

17.67

Tablet 40 mg

MK

30

12.75

17.67

Felodipine

Tablet 2.5 mg (extended release)

AP

30

9.35

12.09

Tablet 5 mg (extended release)

AP

30

12.87

15.92

Tablet 10 mg (extended release)

AP

30

23.04

27.28

Flecainide Acetate

Tablet 100 mg

MM

60

36.62

39.14

Flucloxacillin Magnesium with Water - Purified BP

Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL

GK

1

8.53

8.61

Flucloxacillin Sodium

Capsule equivalent to 250 mg flucloxacillin

GK

24

5.83

6.24

Capsule equivalent to 500 mg flucloxacillin

GK

24

12.20

12.72

Fluoxetine Hydrochloride

Tablet, dispersible, equivalent to 20 mg fluoxetine

LY

28

20.11

23.72

Capsule equivalent to 20 mg fluoxetine

LY

28

20.11

23.72

Fluvastatin Sodium

Capsule equivalent to 20 mg fluvastatin

NM

28

18.50

19.41

Capsule equivalent to 40 mg fluvastatin

NM

28

22.68

23.58

Fluvoxamine Maleate

Tablet 50 mg

SM

30

16.17

19.60

Tablet 100 mg

SM

30

24.49

27.92

Frusemide

Tablet 20 mg

AV

50

1.51

2.00

Tablet 40 mg

AV

100

2.74

3.72

Gemfibrozil

Tablet 600 mg

PF

60

30.83

33.90

Glibenclamide

Tablet 5 mg

AV

100

4.68

5.76

Gliclazide

Tablet 80 mg

SE

100

8.23

10.59

Glimepiride

Tablet 1 mg

AV

30

3.10

5.29

Tablet 2 mg

AV

30

5.94

8.13

Tablet 3 mg

AV

30

7.62

9.83

Tablet 4 mg

AV

30

9.32

11.52

Glipizide

Tablet 5 mg

PH

100

4.77

8.38

Glyceryl Trinitrate

Tablets 600 micrograms, 100

SI

1

3.21

4.67

Hydrochlorothiazide with Amiloride Hydrochloride

Tablet 50 mg-5 mg

MK

50

2.82

4.32

Hydrocortisone Acetate

Cream 10 mg per g, 30 g

SI

1

1.61

3.25

Cream 10 mg per g, 50 g

DT

1

2.02

2.09

SI

1

2.02

3.64

Ointment 10 mg per g, 30 g

SI

1

1.61

3.25

Ointment 10 mg per g, 50 g

SI

1

2.02

3.64

Hypromellose

Eye drops 3 mg per mL, 15 mL

NV

1

3.63

5.28

Hypromellose with Carbomer 980

Ocular lubricating gel 3 mg-2 mg per g, 10 g

NV

1

3.63

5.28

Hypromellose 4500 with Dextran 70

Eye drops 3 mg-1 mg per mL, 15 mL

AQ

1

3.63

5.11

Imipramine Hydrochloride

Tablet 10 mg

NV

50

1.76

2.57

Tablet 25 mg

NV

50

1.76

2.84

Indapamide Hemihydrate

Tablet 2.5 mg

SE

90

12.83

15.79

Indomethacin

Capsule 25 mg

MK

50

1.75

3.10

Ipratropium Bromide

Nebuliser solution 250 micrograms (anhydrous) in 1 mL single dose units, 30

BY

1

17.89

18.31

Nebuliser solution 500 micrograms (anhydrous) in 1 mL single dose units, 30

BY

1

21.15

21.56

Iron Polymaltose Complex

Injection 100 mg (iron) in 2 mL ampoule

BX

5

41.90

42.98

Isosorbide Dinitrate

Tablet 10 mg

SI

100

3.29

4.91

Isosorbide Mononitrate

Tablet 60 mg (sustained release)

AP

30

7.49

10.00

Tablet 120 mg (sustained release)

AP

30

17.76

20.40

Isotretinoin

Capsule 20 mg

RO

60

127.43

129.63

Ketoprofen

Capsule 200 mg (sustained release)

AV

28

9.32

11.09

Labetalol Hydrochloride

Tablet 100 mg

SI

100

7.85

10.34

Tablet 200 mg

SI

100

13.64

16.26

Lactulose

Solution BP 3.34 g per 5 mL, 500 mL

SM

1

9.05

10.99

Lamotrigine

Tablet 5 mg

GK

56

11.97

12.85

Tablet 25 mg

GK

56

26.64

27.53

Tablet 50 mg

GK

56

44.43

45.31

Tablet 100 mg

GK

56

74.02

74.90

Tablet 200 mg

GK

56

124.35

125.23

Lansoprazole

Sachet containing granules for oral suspension, 30 mg per sachet (unless supplied on an authority prescription)

WY

28

29.04

32.34

Leflunomide

Tablet 10 mg

AV

30

86.94

88.02

Tablet 20 mg

AV

30

132.38

133.45

Lercanidipine Hydrochloride

Tablet 10 mg (unless supplied on an authority prescription)

SM

30

17.28

18.25

Tablet 20 mg (unless supplied on an authority prescription)

SM

30

28.34

31.70

Levetiracetam

Tablet 250 mg (unless supplied on an authority prescription)

UC

60

45.45

51.94

Tablet 500 mg (unless supplied on an authority prescription)

UC

60

75.80

86.63

Tablet 1 g (unless supplied on an authority prescription)

UC

60

126.28

144.32

Levodopa with Carbidopa

Tablet 100 mg-25 mg (anhydrous)

MK

100

30.05

34.80

Tablet 250 mg-25 mg (anhydrous)

MK

100

37.05

39.87

Levonorgestrel with Ethinyloestradiol

Tablets 150 micrograms-30 micrograms, 21

SC

1

2.37

4.91

Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets

SC

1

2.37

4.91

WY

1

2.37

4.51

Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets

SC

1

2.37

4.91

WY

1

2.37

4.51

Lisinopril

Tablet 5 mg

AP

30

8.93

11.34

MK

30

8.93

10.70

Tablet 10 mg

AP

30

13.41

15.82

MK

30

13.41

15.18

Tablet 20 mg

AP

30

16.89

19.30

MK

30

16.89

18.66

Loperamide Hydrochloride

Capsule 2 mg

JC

12

1.71

2.53

Medroxyprogesterone Acetate

Tablet 10 mg

PH

100

22.89

24.34

Tablet 5 mg

PH

56

7.80

9.35

Tablet 10 mg

PH

30

8.37

9.92

Injection 150 mg in 1 mL vial

PH

1

7.30

10.25

Meloxicam

Tablet 7.5 mg

BY

30

15.91

17.54

Tablet 15 mg

BY

30

23.20

24.83

Metformin Hydrochloride

Tablet 500 mg

AL

100

7.73

9.32

MQ

100

7.73

8.97

Tablet 850 mg

AL

60

7.73

9.32

MQ

60

7.73

8.97

Tablet 1 g

AL

90

13.46

15.05

Methyldopa

Tablet 250 mg

MK

100

6.70

9.29

Methylphenidate Hydrochloride

Tablet 10 mg

NV

100

7.88

9.00

Methylprednisolone Acetate

Injection 40 mg in 1 mL vial

PH

5

16.32

16.99

Metoclopramide Hydrochloride

Tablet 10 mg

VT

25

1.41

4.03

Metoprolol Tartrate

Tablet 50 mg

AP

100

5.12

7.99

NV

100

5.12

7.62

Tablet 100 mg

AP

60

6.50

9.35

NV

60

6.50

9.01

Metronidazole

Tablet 400 mg

AV

21

4.18

6.00

Tablet 200 mg

AV

21

1.78

3.53

Mianserin Hydrochloride

Tablet 10 mg

OR

50

8.45

10.21

Tablet 20 mg

OR

50

17.84

20.47

Minocycline Hydrochloride

Tablet equivalent to 50 mg minocycline

SI

60

10.52

11.50

Mirtazapine

Tablet 30 mg

BP

30

24.25

26.23

OR

30

24.25

47.74

Tablet 45 mg

BP

30

40.42

42.41

Moclobemide

Tablet 150 mg

RO

60

16.84

17.67

Tablet 300 mg

RO

60

33.68

35.37

Naproxen

Tablet 250 mg

RO

50

4.23

5.59

Tablet 500 mg

RO

50

7.52

9.11

Tablet 750 mg (sustained release)

RO

28

6.91

8.38

Tablet 1 g (sustained release)

RO

28

9.21

10.77

Naproxen Sodium

Tablet 550 mg

RO

50

7.75

10.40

Nifedipine

Tablet 10 mg

BN

60

12.50

14.07

Tablet 20 mg

BN

60

15.58

18.49

Tablet 20 mg (controlled release) (unless supplied on an authority prescription)

BN

30

15.53

18.53

Tablet 30 mg (controlled release)

BN

30

16.75

20.12

Tablet 60 mg (controlled release)

BN

30

21.05

24.78

Nitrazepam

Tablet 5 mg

VT

25

1.70

3.48

Nizatidine

Capsule 150 mg

AS

60

16.36

21.16

Capsule 300 mg

AS

30

16.36

21.16

Norethisterone

Tablets 350 micrograms, 28

PH

1

2.37

3.25

Norethisterone with Ethinyloestradiol

Tablets 500 micrograms-35 micrograms, 21

PH

1

2.37

4.12

Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets

PH

1

2.37

4.12

Tablets 1 mg-35 micrograms, 21

PH

1

2.37

4.12

Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets

PH

1

2.37

4.12

Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets

PH

1

2.37

4.12

Norfloxacin

Tablet 400 mg

MK

14

13.11

16.39

Omeprazole Magnesium

Tablet equivalent to 20 mg omeprazole

AP

30

26.57

28.99

Ondansetron

Wafer 4 mg

GK

4

30.51

31.13

Wafer 8 mg

GK

4

47.79

48.42

Wafer 4 mg

GK

10

76.26

76.89

Wafer 8 mg

GK

10

119.47

120.09

Ondansetron Hydrochloride Dihydrate

Tablet equivalent to 4 mg ondansetron

GK

4

30.51

31.13

Tablet equivalent to 8 mg ondansetron

GK

4

47.79

48.42

Tablet equivalent to 4 mg ondansetron

GK

10

76.26

76.89

Tablet equivalent to 8 mg ondansetron

GK

10

119.47

120.09

I.V. injection equivalent to 4 mg ondansetron in 2 mL ampoule

GK

1

17.20

17.83

I.V. injection equivalent to 8 mg ondansetron in 4 mL ampoule

GK

1

27.33

27.94

Oxazepam

Tablet 15 mg

SI

25

1.13

2.40

Tablet 30 mg

SI

25

1.31

2.95

Paracetamol

Tablet 665 mg (modified release)

GC

96

2.97

5.12

Paraffin - Soft White with Paraffin - Liquid

Eye ointment, compound, 3.5 g

AQ

1

6.34

7.21

Pack containing 2 tubes eye ointment, compound, 3.5 g

AG

1

12.67

14.56

Paroxetine Hydrochloride

Tablet equivalent to 20 mg paroxetine

GK

30

22.87

23.84

Pemetrexed Disodium Heptahydrate

Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial (unless supplied on an authority prescription)

LY

1

1,430.56

1,629.92

Phenoxymethylpenicillin Benzathine

Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL

SI

1

3.34

4.16

Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL

SI

1

4.56

5.38

Pilocarpine Hydrochloride

Eye drops 5 mg per mL, 15 mL

AG

1

5.01

7.31

Eye drops 10 mg per mL, 15 mL

AG

1

5.01

7.31

Eye drops 20 mg per mL, 15 mL

AG

1

6.03

8.31

Eye drops 30 mg per mL, 15 mL

AG

1

8.37

10.64

Eye drops 40 mg per mL, 15 mL

AG

1

8.37

10.64

Eye drops 60 mg per mL, 15 mL

AG

1

12.05

14.26

Pindolol

Tablet 5 mg

NV

100

5.87

8.34

Tablet 15 mg

NV

50

8.45

10.90

Piperazine Oestrone Sulfate

Tablet 730 micrograms

PH

56

4.95

6.25

Tablet 1.46 mg

PH

56

7.05

8.37

Piroxicam

Dispersible tablet 10 mg

PF

50

7.05

9.47

Dispersible tablet 20 mg

PF

25

6.70

9.10

Capsule 10 mg

PF

50

7.05

9.47

Capsule 20 mg

PF

25

6.70

9.10

Polyvinyl Alcohol

Eye drops 14 mg per mL, 15 mL

AG

1

3.63

5.14

Eye drops 30 mg per mL, 15 mL

AG

1

3.63

8.90

Potassium Chloride

Tablet 600 mg (sustained release)

NV

100

2.63

3.84

Potassium Chloride with Potassium Bicarbonate

Tablet, effervescent, 14 mmol K+ and 8 mmol Cl-

AS

60

5.37

7.68

Pravastatin Sodium

Tablet 10 mg

BQ

30

22.08

22.51

Tablet 20 mg

BQ

30

35.08

35.52

Tablet 40 mg

BQ

30

54.64

55.09

Tablet 80 mg

BQ

30

83.76

84.21

Prazosin Hydrochloride

Tablet equivalent to 1 mg prazosin

PF

100

7.19

9.87

Tablet equivalent to 2 mg prazosin

PF

100

9.86

12.63

Tablet equivalent to 5 mg prazosin

PF

100

16.73

19.72

Prednisolone

Tablet 1 mg

AS

100

2.09

2.63

Prednisolone Sodium Phosphate

Oral solution equivalent to 5 mg prednisolone per mL, 30 mL

AS

1

7.06

8.41

Prednisone

Tablet 1 mg

AS

100

2.09

2.63

Prochlorperazine Maleate

Tablet 5 mg

AV

25

2.28

4.18

Propranolol Hydrochloride

Tablet 10 mg

AP

100

2.61

5.26

Tablet 40 mg

AP

100

2.73

5.38

Quinapril Hydrochloride

Tablet equivalent to 5 mg quinapril

PF

30

9.53

9.97

Tablet equivalent to 10 mg quinapril

PF

30

13.43

14.03

Tablet equivalent to 20 mg quinapril

PF

30

16.56

17.45

Quinine Sulfate

Tablet 300 mg

AS

50

4.73

6.66

Ramipril

Tablet 1.25 mg (unless supplied on an authority prescription)

AV

30

6.35

9.08

ML

30

6.35

7.26

Tablet 2.5 mg (unless supplied on an authority prescription)

AV

30

9.28

12.01

ML

30

9.28

10.61

Tablet 5 mg (unless supplied on an authority prescription)

AV

30

11.64

14.36

ML

30

11.64

13.30

Capsule 10 mg (unless supplied on an authority prescription)

AV

30

20.54

23.47

ML

30

20.54

23.47

Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg (unless supplied on an authority prescription)

AV

1

18.09

20.67

Tablet 1.25 mg (if supplied on an authority prescription)

AV

30

7.26

9.08

Tablet 2.5 mg (if supplied on an authority prescription)

AV

30

10.61

12.01

Tablet 5 mg (if supplied on an authority prescription)

AV

30

13.30

14.36

Ranitidine Hydrochloride

Tablet equivalent to 150 mg ranitidine

GK

60

13.28

15.25

Tablet, effervescent, equivalent to 150 mg ranitidine (unless supplied on an authority prescription)

GK

30

7.60

8.55

Tablet equivalent to 300 mg ranitidine

GK

30

13.28

15.25

Syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL (unless supplied on an authority prescription)

GK

1

6.65

7.61

Roxithromycin

Tablet 150 mg

AV

10

6.18

8.38

Tablet 300 mg

AV

5

6.18

8.38

Salbutamol Sulfate

Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation)

GK

1

5.11

5.56

MM

1

5.11

5.38

Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30

GK

1

8.29

9.26

Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30

GK

1

8.76

9.73

Sertraline Hydrochloride

Tablet equivalent to 50 mg sertraline

PF

30

22.78

23.27

Tablet equivalent to 100 mg sertraline

PF

30

22.78

23.27

Simvastatin

Tablet 5 mg

FR

30

19.56

20.18

MK

30

19.56

20.18

Tablet 10 mg

FR

30

27.04

27.65

MK

30

27.04

27.65

Tablet 20 mg

FR

30

38.86

39.48

MK

30

38.86

39.48

Tablet 40 mg

FR

30

55.93

56.56

MK

30

55.93

56.56

Tablet 80 mg

FR

30

80.37

80.98

MK

30

80.37

80.98

Sodium Valproate

Tablet 200 mg (enteric coated)

SW

100

13.91

14.49

Tablet 500 mg (enteric coated)

SW

100

27.54

28.26

Sotalol Hydrochloride

Tablet 80 mg

BQ

60

10.85

12.31

Tablet 160 mg

BQ

60

23.28

24.86

Spironolactone

Tablet 25 mg

PH

100

7.04

8.71

Tablet 100 mg

PH

100

27.71

30.01

Sucralfate

Tablet equivalent to 1 g anhydrous sucralfate

AS

120

15.96

17.90

Sulfasalazine

Tablet 500 mg (enteric coated)

PH

100

23.48

24.21

Tamoxifen Citrate

Tablet equivalent to 10 mg tamoxifen

AP

30

18.82

19.78

Tablet equivalent to 20 mg tamoxifen

AP

30

32.62

34.35

Temazepam

Tablet 10 mg

SI

25

1.70

3.08

Terbinafine Hydrochloride

Tablet equivalent to 250 mg terbinafine

NV

42

116.85

118.61

Thyroxine Sodium

Tablet equivalent to 50 micrograms anhydrous thyroxine sodium

SI

200

13.52

14.67

Tablet equivalent to 100 micrograms anhydrous thyroxine sodium

SI

200

14.47

15.63

Tablet equivalent to 200 micrograms anhydrous thyroxine sodium

SI

200

19.21

20.35

Ticlopidine Hydrochloride

Tablet 250 mg

RO

60

129.93

131.93

Timolol Maleate

Eye drops equivalent to 2.5 mg timolol per mL, 5 mL

FR

1

6.24

7.19

Eye drops equivalent to 5 mg timolol per mL, 5 mL

FR

1

7.19

8.19

Tinidazole

Tablet 500 mg

PF

4

2.47

4.69

Topiramate

Tablet 25 mg (unless supplied on an authority prescription)

JC

60

30.31

32.42

Tablet 50 mg (unless supplied on an authority prescription)

JC

60

50.53

52.64

Tablet 100 mg (unless supplied on an authority prescription)

JC

60

84.19

86.56

Tablet 200 mg (unless supplied on an authority prescription)

JC

60

141.43

143.81

Capsule 15 mg (unless supplied on an authority prescription)

JC

60

21.83

23.94

Capsule 25 mg (unless supplied on an authority prescription)

JC

60

30.31

32.42

Capsule 50 mg (unless supplied on an authority prescription)

JC

60

50.53

52.64

Tramadol Hydrochloride

Capsule 50 mg

CS

20

3.17

4.49

Tablet 100 mg (sustained release)

CS

20

8.63

10.39

Tablet 150 mg (sustained release)

CS

20

11.63

13.39

Tablet 200 mg (sustained release)

CS

20

14.16

15.91

Trandolapril

Capsule 500 micrograms

KN

28

7.59

8.95

Capsule 1 mg

KN

28

12.06

13.43

Capsule 2 mg

KN

28

13.06

14.43

Triamcinolone Acetonide

Cream 200 micrograms per g, 100 g

SI

1

3.76

4.90

Ointment 200 micrograms per g, 100 g

SI

1

3.76

4.90

Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin

Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL

BQ

1

2.08

3.04

Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g

BQ

1

1.65

2.61

Trimethoprim

Tablet 300 mg

SI

7

2.39

3.59

Trimethoprim with Sulfamethoxazole

Tablet 160 mg-800 mg

SI

10

3.44

4.72

Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL

SI

1

3.05

4.74

Verapamil Hydrochloride

Tablet 40 mg

AB

100

5.90

6.78

Tablet 80 mg

AB

100

10.48

11.36

Tablet 180 mg (sustained release)

AB

30

8.46

11.09

Tablet 240 mg (sustained release)

AB

30

11.28

13.91

\n```\n\nDated this 26th day of July 2006.\n\n| |\n| ------------------------------------------------------------------------------------------------------------------------------------------ |\n| JOAN CORBETTAssistant SecretaryPharmaceutical Benefits BranchDepartment of Health and AgeingDelegate of the Minister for Health and Ageing |","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":2117},"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"This is a routine administrative update to the PBS pricing schedule. It repeals the previous determination (No. PB 27 of 2006) and updates the listed prices and quantities. It operates entirely within the existing statutory framework for pharmaceutical benefits and does not expand the scope beyond the standard pricing mechanism established by the National Health Act 1953."},"complexity_factors":["Extensive tabular Schedule with over 250 individual drug formulations, strengths, and pack sizes","Conditional logic requiring cross-checking for 'authority prescription' status on numerous items","Dual pricing columns (manufacturer's price vs claimed price) requiring reconciliation","Manufacturer identification via abbreviations requiring cross-reference to the interpretation table (e.g., mapping 'GK' to GlaxoSmithKline)","Transitional exception clause in section 8 creating a date-based conditional exclusion for specific drug supply","Multiple cross-references to parent Act sections (85, 85A, 85B, 88) for application and definitions"],"plain_english_summary":"This Determination fixes the subsidised \"manufacturer's price\" and claimed price, and the allowable pack quantities, for hundreds of PBS-listed prescription medicines, and clarifies that an \"authority prescription\" is one authorised under the National Health Act. It also includes a temporary transitional exception for lansoprazole. It affects patients, dispensing pharmacists and listed manufacturers by setting the benchmark the government uses to reimburse pharmacies and ensure national consistency in medicine costs."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006","history":"/api/acts/national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006/history","analysis":"/api/acts/national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006/analysis","conflicts":"/api/acts/national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006/conflicts","importantCases":"/api/acts/national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006/important-cases","documents":"/api/acts/national-health-act-1953-determination-under-subsection-85b-1-no-pb-34-of-2006/documents"}}